Drug accountability is tricky business [Off Topic]

posted by ElMaestro  – Denmark, 2017-04-07 15:35  – Posting: # 17233
Views: 1,149

Hi all,

I have to admit, when I audit or inspect I always do D.A. 'by manual count' if circumstances allow, and I usually do not get it right in the first attempt. It usually takes several tries and re-reading of dosing forms, receipt records, pharmacy binders etc., before the figures check out even though this is only a matter of addition and subtraction. It is rather comforting to see that I am not the only one who is occasionally struggling.

:-D:-D:-D
Wishing you all a good weekend.

if (3) 4

x=c("Foo", "Bar")
b=data.frame(x)
typeof(b[,1]) ##aha, integer?
b[,1]+1 ##then let me add 1


Best regards,
ElMaestro

“(...) targeted cancer therapies will benefit fewer than 2 percent of the cancer patients they’re aimed at. That reality is often lost on consumers, who are being fed a steady diet of winning anecdotes about miracle cures.” New York Times (ed.), June 9, 2018.

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,475 posts in 4,131 threads, 1,333 registered users;
online 7 (1 registered, 6 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 11:24 UTC

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5